| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/16/2010 | US20100233174 Anthrax carbohydrates, synthesis and uses thereof |
| 09/16/2010 | US20100233171 Differential Drug Sensitivity |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233165 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 09/16/2010 | US20100233164 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies |
| 09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
| 09/16/2010 | US20100233142 Stem Cells Derived from Uniparental Embryos and Methods of Use Thereof |
| 09/16/2010 | US20100233136 Isolated populations of cells and methods of generating and using same |
| 09/16/2010 | US20100233085 Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same |
| 09/16/2010 | US20100233084 Method for Delivery Across the Blood Brain Barrier |
| 09/16/2010 | DE112008003229T5 Verfahren zum Nachweisen von Nukleinsäuren durch gleichzeitige isothermale Amplifikation von Nukleinsäuren und Signalsonde A method for detecting nucleic acids by simultaneous isothermal amplification of nucleic acids and probe signal |
| 09/16/2010 | DE102009013957A1 Verfahren und Mittel zum Nachweis der Aktivität von Osteoklasten Methods and means for detecting the activity of osteoclasts |
| 09/16/2010 | DE102009012039A1 Quantifizierung von Nukleinsäuren Quantification of nucleic acids |
| 09/16/2010 | CA2755394A1 Methods and compositions for cell-proliferation-related disorders |
| 09/16/2010 | CA2755358A1 Novel markers for bladder cancer detection |
| 09/16/2010 | CA2755341A1 Method |
| 09/16/2010 | CA2755301A1 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 09/16/2010 | CA2755234A1 Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same |
| 09/16/2010 | CA2755207A1 Reagents and methods for pcr |
| 09/16/2010 | CA2754392A1 Tissue-specific aging biomarkers |
| 09/16/2010 | CA2754056A1 Mirac proteins |
| 09/16/2010 | CA2753894A1 Immuno-based retargeted endopeptidase activity assays |
| 09/16/2010 | CA2753282A1 Use of serine protease inhibitors in the treatment of neutropenia |
| 09/16/2010 | CA2735242A1 Cells useful for immuno-based botulinum toxin serotype a activity assays |
| 09/15/2010 | EP2228655A1 Method of predicting metastatic potential, poor prognosis or lower overall survival of cancer patients |
| 09/15/2010 | EP2228654A2 Diagnosis and prevention of cancer cell invasion |
| 09/15/2010 | EP2228653A2 Multichemistry measuring device and test strips |
| 09/15/2010 | EP2228642A1 Systems and methods for improving electrochemical analyte sensors |
| 09/15/2010 | EP2228457A1 Gene expression markers of recurrence risk in cancer patients after chemotherapy |
| 09/15/2010 | EP2228456A1 Selection of encoding nucleic acid constructs for absence of frameshift mutations |
| 09/15/2010 | EP2228455A1 Diagnosis of HER-2 positive breast cancer |
| 09/15/2010 | EP2228454A1 Multiplex quantitative nucleic acid amplification and melting assay |
| 09/15/2010 | EP2228453A1 Preservation of fetal nucleic acids in maternal plasma |
| 09/15/2010 | EP2228452A1 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent |
| 09/15/2010 | EP2228451A1 Method for determining the primary site of cup |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228445A1 Fucose Transporter |
| 09/15/2010 | EP2228443A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/15/2010 | EP2228440A1 Variants of beta-glucosidases |
| 09/15/2010 | EP2228436A1 Centrifugation and filtration methods for concentrating microorganisms |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228379A1 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 09/15/2010 | EP2228069A1 Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith. |
| 09/15/2010 | EP2227780A2 Genetic analysis |
| 09/15/2010 | EP2227693A2 Tle3 as a marker for chemotherapy |
| 09/15/2010 | EP2227681A2 Sers-based, single step, real-time detection of protein kinase and/or phosphatase activity |
| 09/15/2010 | EP2227569A2 Methods and compositions relating to multiplexed genomic gain and loss assays |
| 09/15/2010 | EP2227568A1 Molecular in vitro diagnosis of breast cancer |
| 09/15/2010 | EP2227567A2 Sensors for measuring contaminants |
| 09/15/2010 | EP2227564A2 Multiplexed genomic gain and loss assays |
| 09/15/2010 | EP2227562A2 Assay for detecting genetic abnormalities in genomic nucleic acids |
| 09/15/2010 | EP2227560A1 Methods for the treatment and diagnosis of bone mineral density related diseases |
| 09/15/2010 | EP2227559A1 Thermal cycling device |
| 09/15/2010 | EP2227558A1 Method for classifying cancer patients as responder or non-responder to immunotherapy |
| 09/15/2010 | EP2227557A1 Marker assisted directed evolution |
| 09/15/2010 | EP2227556A2 Lung cancer markers and uses thereof |
| 09/15/2010 | EP2227555A1 Means and methods for the detection and isolation of fetal and embryonic cells and nucleic acid from maternal body fluid |
| 09/15/2010 | EP2227554A1 Detection of inducible resistance to macrolide-lincosamide-streptogramin b |
| 09/15/2010 | EP2227547A1 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof |
| 09/15/2010 | EP2227537A1 A reactor for the quantitative analysis of nucleic acids |
| 09/15/2010 | EP2227483A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/15/2010 | EP2227331A2 Automated analyzer for clinical laboratory |
| 09/15/2010 | EP2038425B1 High throughput physical mapping using aflp |
| 09/15/2010 | EP1960550B1 Probe for nucleic acid sequencing and methods of use |
| 09/15/2010 | EP1824997B1 Genetic alteration useful for the response prediction of malignant neoplasia to taxane-based medical treatment |
| 09/15/2010 | EP1730311B1 A method of genotyping blood cell antigens and kit suitable for genotyping blood cell antigens |
| 09/15/2010 | EP1721015B1 Primer and probe design for efficient amplification and detection of hcv 3' non-translating region |
| 09/15/2010 | EP1627230B1 Predicting cancer progression |
| 09/15/2010 | EP1576179B1 Methods and compositions for inducing apoptosis in cancer cells |
| 09/15/2010 | EP1543838B1 Feline infectious peritonitis vaccine |
| 09/15/2010 | EP1430140B1 N-terminally truncated isoforms of pde3a cyclic phosphodiesterases |
| 09/15/2010 | EP1354196B1 Diagnostics, drug screening and treatment for cancer |
| 09/15/2010 | EP1220944B1 Nuclease inhibitor cocktail |
| 09/15/2010 | EP1117996B1 Method for producing biochemical reaction supporting materials |
| 09/15/2010 | CN201583544U Membrane biological chip chromatography reaction card and reacting device provided with same |
| 09/15/2010 | CN201581082U Detecting device |
| 09/15/2010 | CN201581079U Polymerase chain reaction-capillary electrophoresis combined micro-fluidic chip laser-induced fluorescence analyzing device |
| 09/15/2010 | CN201581078U Detecting plate |
| 09/15/2010 | CN1967233B Electrochemical cell |
| 09/15/2010 | CN1644710B Method for microbial antibiotic resistance detection |
| 09/15/2010 | CN101836117A A rapid and sensitive method for detection of biological targets |
| 09/15/2010 | CN101836116A Method for detection of cancer |
| 09/15/2010 | CN101835908A Methods and compositions for diagnosing disease |
| 09/15/2010 | CN101835907A Methods and systems for solution based sequence enrichment and analysis of genomic regions |
| 09/15/2010 | CN101835906A Nucleic acid probe, and method for production of probe polymer |
| 09/15/2010 | CN101835905A Method and kit for detection/quantification of target rna |
| 09/15/2010 | CN101835904A Method of selecting aptamers |
| 09/15/2010 | CN101835903A Methods for detecting oligonucleotides |
| 09/15/2010 | CN101835902A Ultraconserved regions encoding ncrnas |
| 09/15/2010 | CN101835901A High throughput screening of genetically modified photosynthetic organisms |
| 09/15/2010 | CN101835900A A method for DNA breakpoint analysis |
| 09/15/2010 | CN101835899A Method for identifying a compound that modulates telomerase activity |
| 09/15/2010 | CN101835897A Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 09/15/2010 | CN101832997A Application of gold nanoparticles serving as glucose oxidase |
| 09/15/2010 | CN101832986A Kit for detecting pesticide by using thin layer chromatography-enzymatic inhibition method and preparation method of cholinesterase bar |
| 09/15/2010 | CN101832919A Screening method of medicines for restraining beta-amyloid deposition |
| 09/15/2010 | CN101831510A Real-time fluorescent quantitative PCR detection method and reagent kit for simian foamy virus |
| 09/15/2010 | CN101831509A Method for titrating rabies viruses quickly with cell plaques |
| 09/15/2010 | CN101831508A Quantitative detection method of tea-geometrid-type polyhedrosis viruses |